{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042963","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2026-09-16T21:30:31+00:00","discovered_at":"2026-09-16T21:32:17.554546+00:00","generated_at":"2026-09-16T21:32:28.500332+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Ernexa Therapeutics posts corporate fact sheet and investor presentation; no specifics disclosed","bullets":["Ernexa Therapeutics (ERNA) made available a corporate fact sheet and investor presentation dated September 16, 2026, via website and SEC filing.","No financial or operational data appears in the exhibits of this filing; specific content not provided.","Materials made available on company website on September 17, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042963","json":"https://secwatch.observer/filing/0001493152-26-042963.json","markdown":"https://secwatch.observer/filing/0001493152-26-042963.md","text":"https://secwatch.observer/filing/0001493152-26-042963.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000149315226042963/0001493152-26-042963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000149315226042963/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T21:32:28.500332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}